SPRC — Scisparc Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $3.13m
- $1.58m
- $1.31m
Annual cashflow statement for Scisparc, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.54 | -5.79 | -2.59 | -5.88 | -7.47 |
Depreciation | |||||
Non-Cash Items | 0.41 | 0.052 | -4.81 | 0.291 | 1.75 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.35 | 0.643 | -0.703 | -0.833 | 0.136 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.31 | -5.06 | -7.92 | -5.89 | -5.1 |
Capital Expenditures | 0 | -0.035 | -4.87 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.024 | -0.035 | -2.21 | -1.11 | -1.63 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.024 | -0.07 | -7.08 | -1.11 | -1.63 |
Financing Cash Flow Items | 0.109 | 0 | -0.005 | -0.007 | -0.008 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.36 | 10.1 | 11.7 | 5.5 | 6.19 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.08 | 4.93 | -3.3 | -1.5 | -0.536 |